Population
Human platelets (in vitro study)
Design
Preclinical
Authors
Loading...
TxA2 involvement varies by agonist in animal platelets; hypothesis-generating and should not yet change human antiplatelet practice.
Thromboxane A2 involvement in platelet aggregation varies depending on the stimulating agent.
MASHIMO et al. (1979) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: